Sookpotarom Pol, Namkaew Jirapat, Wuttisa Kaikwa, Chantarangkul Chantanapa, Jamjuree Praewpannarai, Jaroonwitchawan Thiranut, Taweechotipatr Malai
Doctor of Medicine Program, Faculty of Medicine, Srinakharinwirot University, Bangkok 10110, Thailand.
Futuristic Science Research Center, School of Science, Walailak University, Thasala, Nakhon Si Thammarat 80160, Thailand.
Foods. 2025 May 25;14(11):1874. doi: 10.3390/foods14111874.
Kidney fibrosis and inflammation are significant contributors to the decline in renal function associated with aging. These processes are characterized by structural changes, such as glomerular sclerosis and interstitial fibrosis, which exacerbate kidney injury and inflammation in aged individuals. Probiotics have gained increasing attention for their potential health-promoting effects. However, further investigation is required to fully understand the mechanisms underlying these benefits. We hypothesize that probiotics could ameliorate fibrosis through the immunomodulatory effects of probiotics and by improving kidney tissue inflammation. Sixteen-month-old aging mice were administered MSMC39-1 for four months compared to young mice (six-month-old) and aged mice (twenty-month-old). The research found that following the administration of probiotic MSMC39-1, there were significant improvements in kidney inflammation, as evidenced by reductions in pro-inflammatory cytokines, fibrosis, and inflammatory cells within the tissue. Moreover, the findings demonstrated that probiotic MSMC39-1 significantly normalized levels of malondialdehyde (MDA), and rescued antioxidant superoxide dismutase (SOD) and glutathione peroxidase (Gpx) in kidney tissue which was consistent with a low mitochondria biogenesis. Further investigations revealed that conditioned medium from MSMC39-1 rescued epithelial kidney cells with damage induced by high glucose. This research provides information and insights into the mechanisms underlying the beneficial health effects of probiotics, offering a deeper understanding of how these probiotics contribute to anti-aging processes in the kidney.
肾纤维化和炎症是导致与衰老相关的肾功能下降的重要因素。这些过程的特征是结构变化,如肾小球硬化和间质纤维化,这会加剧老年个体的肾损伤和炎症。益生菌因其潜在的促进健康作用而越来越受到关注。然而,需要进一步研究以充分了解这些益处背后的机制。我们假设益生菌可以通过其免疫调节作用和改善肾组织炎症来减轻纤维化。将16月龄的衰老小鼠与年轻小鼠(6月龄)和老年小鼠(20月龄)相比,给予MSMC39-1四个月。研究发现,给予益生菌MSMC39-1后,肾脏炎症有显著改善,组织内促炎细胞因子、纤维化和炎症细胞减少证明了这一点。此外,研究结果表明,益生菌MSMC39-1可显著使丙二醛(MDA)水平正常化,并挽救肾组织中的抗氧化超氧化物歧化酶(SOD)和谷胱甘肽过氧化物酶(Gpx),这与低线粒体生物发生一致。进一步研究表明,MSMC39-1的条件培养基可挽救高糖诱导损伤的肾上皮细胞。这项研究提供了关于益生菌有益健康作用背后机制的信息和见解,有助于更深入地理解这些益生菌如何促进肾脏的抗衰老过程。